Matches in Wikidata for { <http://www.wikidata.org/entity/Q100315319> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q100315319 description "article scientifique publié en 2020" @default.
- Q100315319 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q100315319 description "scientific article published on 28 September 2020" @default.
- Q100315319 description "wetenschappelijk artikel" @default.
- Q100315319 description "наукова стаття, опублікована 28 вересня 2020" @default.
- Q100315319 name "Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al" @default.
- Q100315319 name "Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al" @default.
- Q100315319 type Item @default.
- Q100315319 label "Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al" @default.
- Q100315319 label "Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al" @default.
- Q100315319 prefLabel "Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al" @default.
- Q100315319 prefLabel "Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al" @default.
- Q100315319 P1433 Q100315319-72285CBC-DC12-438F-A8EF-0E9AE7A4DDDA @default.
- Q100315319 P1476 Q100315319-E9477223-A019-458F-BA9D-7F980B1520DF @default.
- Q100315319 P2093 Q100315319-0FAB32AD-BF44-4C88-8EB3-66EC325C81BD @default.
- Q100315319 P2093 Q100315319-71CCAA8E-4E8B-49E8-88A6-BD044E970E20 @default.
- Q100315319 P31 Q100315319-A0BB9CD1-D36F-4418-B0A8-B3D561B0D8A4 @default.
- Q100315319 P356 Q100315319-24D52F06-71D4-46F2-8C0C-94FA2DEBD85E @default.
- Q100315319 P50 Q100315319-E9AA8837-ADCE-4F8E-A574-13A0B09B36EC @default.
- Q100315319 P577 Q100315319-EFA723D2-1529-4D71-A557-7101111FA2FD @default.
- Q100315319 P698 Q100315319-A275189A-CE84-4F16-8107-7F5105C96F9E @default.
- Q100315319 P921 Q100315319-854A4AA9-284B-4602-9BC8-01C2E3FC2865 @default.
- Q100315319 P921 Q100315319-A37A68A5-9FE2-4071-BE4D-C06300E3AA7D @default.
- Q100315319 P356 ANNRHEUMDIS-2020-218402 @default.
- Q100315319 P698 32988836 @default.
- Q100315319 P1433 Q4767876 @default.
- Q100315319 P1476 "Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al" @default.
- Q100315319 P2093 "Fang Xiao Zhu" @default.
- Q100315319 P2093 "Jing-Yang Huang" @default.
- Q100315319 P31 Q13442814 @default.
- Q100315319 P356 "10.1136/ANNRHEUMDIS-2020-218402" @default.
- Q100315319 P50 Q88152562 @default.
- Q100315319 P577 "2020-09-28T00:00:00Z" @default.
- Q100315319 P698 "32988836" @default.
- Q100315319 P921 Q1485 @default.
- Q100315319 P921 Q582207 @default.